Not applicableUnknownNCT03029858
What this trial is testing
PD-L1 and Other Immuno-markers Influenced by Osimertinib Treatment in Advanced NSCLC Patients
Who this might be right for
Small Cell Lung Cancer, Polygonal Type
Guangdong Association of Clinical Trials 155